These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27979044)

  • 1. Serum brain-derived neurotrophic factor and risk of atrial fibrillation.
    Rahman F; Himali JJ; Yin X; Beiser AS; Ellinor PT; Lubitz SA; Vasan RS; Magnani JW; McManus DD; Seshadri S; Benjamin EJ
    Am Heart J; 2017 Jan; 183():69-73. PubMed ID: 27979044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin 3 and incident atrial fibrillation in the community.
    Ho JE; Yin X; Levy D; Vasan RS; Magnani JW; Ellinor PT; McManus DD; Lubitz SA; Larson MG; Benjamin EJ
    Am Heart J; 2014 May; 167(5):729-34.e1. PubMed ID: 24766984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study.
    Khan AM; Lubitz SA; Sullivan LM; Sun JX; Levy D; Vasan RS; Magnani JW; Ellinor PT; Benjamin EJ; Wang TJ
    Circulation; 2013 Jan; 127(1):33-8. PubMed ID: 23172839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart Study.
    Weinstein G; Beiser AS; Choi SH; Preis SR; Chen TC; Vorgas D; Au R; Pikula A; Wolf PA; DeStefano AL; Vasan RS; Seshadri S
    JAMA Neurol; 2014 Jan; 71(1):55-61. PubMed ID: 24276217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum brain-derived neurotrophic factor and vascular endothelial growth factor levels are associated with risk of stroke and vascular brain injury: Framingham Study.
    Pikula A; Beiser AS; Chen TC; Preis SR; Vorgias D; DeCarli C; Au R; Kelly-Hayes M; Kase CS; Wolf PA; Vasan RS; Seshadri S
    Stroke; 2013 Oct; 44(10):2768-75. PubMed ID: 23929745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating brain-derived neurotrophic factor concentrations and the risk of cardiovascular disease in the community.
    Kaess BM; Preis SR; Lieb W; Beiser AS; Yang Q; Chen TC; Hengstenberg C; Erdmann J; Schunkert H; Seshadri S; Vasan RS; ; Assimes TL; Deloukas P; Holm H; Kathiresan S; König IR; McPherson R; Reilly MP; Roberts R; Samani NJ; Stewart AF
    J Am Heart Assoc; 2015 Mar; 4(3):e001544. PubMed ID: 25762803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Vascular Cell Adhesion Molecule 1 and Atrial Fibrillation.
    Willeit K; Pechlaner R; Willeit P; Skroblin P; Paulweber B; Schernthaner C; Toell T; Egger G; Weger S; Oberhollenzer M; Kedenko L; Iglseder B; Bonora E; Schett G; Mayr M; Willeit J; Kiechl S
    JAMA Cardiol; 2017 May; 2(5):516-523. PubMed ID: 28355442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation.
    Rienstra M; Yin X; Larson MG; Fontes JD; Magnani JW; McManus DD; McCabe EL; Coglianese EE; Amponsah M; Ho JE; Januzzi JL; Wollert KC; Fradley MG; Vasan RS; Ellinor PT; Wang TJ; Benjamin EJ
    Am Heart J; 2014 Jan; 167(1):109-115.e2. PubMed ID: 24332149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating fibroblast growth factor-23 and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities study.
    Alonso A; Misialek JR; Eckfeldt JH; Selvin E; Coresh J; Chen LY; Soliman EZ; Agarwal SK; Lutsey PL
    J Am Heart Assoc; 2014 Sep; 3(5):e001082. PubMed ID: 25237047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study.
    Rienstra M; Sun JX; Lubitz SA; Frankel DS; Vasan RS; Levy D; Magnani JW; Sullivan LM; Meigs JB; Ellinor PT; Benjamin EJ
    Am Heart J; 2012 Jan; 163(1):119-124.e1. PubMed ID: 22172445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Remnant Cholesterol and Risk of Incident Atrial Fibrillation: Population-Based Evidence From a Large-Scale Prospective Cohort Study.
    Li L; Wang C; Ye Z; Van Spall HGC; Zhang J; Lip GYH; Li G
    J Am Heart Assoc; 2024 May; 13(10):e033840. PubMed ID: 38761084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study.
    Magnani JW; Moser CB; Murabito JM; Sullivan LM; Wang N; Ellinor PT; Vasan RS; Benjamin EJ; Coviello AD
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):307-12. PubMed ID: 24610804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of circulating liver transaminase concentrations to risk of new-onset atrial fibrillation.
    Sinner MF; Wang N; Fox CS; Fontes JD; Rienstra M; Magnani JW; Vasan RS; Calderwood AH; Pencina M; Sullivan LM; Ellinor PT; Benjamin EJ
    Am J Cardiol; 2013 Jan; 111(2):219-24. PubMed ID: 23127690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma total testosterone and risk of incident atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.
    Berger D; Folsom AR; Schreiner PJ; Chen LY; Michos ED; O'Neal WT; Soliman EZ; Alonso A
    Maturitas; 2019 Jul; 125():5-10. PubMed ID: 31133217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum 25-hydroxyvitamin D and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study.
    Alonso A; Misialek JR; Michos ED; Eckfeldt J; Selvin E; Soliman EZ; Chen LY; Gross MD; Lutsey PL
    Europace; 2016 Aug; 18(8):1143-9. PubMed ID: 26847078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid Function Within the Normal Range, Subclinical Hypothyroidism, and the Risk of Atrial Fibrillation.
    Baumgartner C; da Costa BR; Collet TH; Feller M; Floriani C; Bauer DC; Cappola AR; Heckbert SR; Ceresini G; Gussekloo J; den Elzen WPJ; Peeters RP; Luben R; Völzke H; Dörr M; Walsh JP; Bremner A; Iacoviello M; Macfarlane P; Heeringa J; Stott DJ; Westendorp RGJ; Khaw KT; Magnani JW; Aujesky D; Rodondi N;
    Circulation; 2017 Nov; 136(22):2100-2116. PubMed ID: 29061566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of hypothyroidism and incident atrial fibrillation (from the Framingham Heart Study).
    Kim EJ; Lyass A; Wang N; Massaro JM; Fox CS; Benjamin EJ; Magnani JW
    Am Heart J; 2014 Jan; 167(1):123-6. PubMed ID: 24332151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary factors and incident atrial fibrillation: the Framingham Heart Study.
    Shen J; Johnson VM; Sullivan LM; Jacques PF; Magnani JW; Lubitz SA; Pandey S; Levy D; Vasan RS; Quatromoni PA; Junyent M; Ordovas JM; Benjamin EJ
    Am J Clin Nutr; 2011 Feb; 93(2):261-6. PubMed ID: 21106919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein Biomarkers and Risk of Atrial Fibrillation: The FHS.
    Staerk L; Preis SR; Lin H; Lubitz SA; Ellinor PT; Levy D; Benjamin EJ; Trinquart L
    Circ Arrhythm Electrophysiol; 2020 Feb; 13(2):e007607. PubMed ID: 31941368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid profile and incidence of atrial fibrillation: A prospective cohort study in China.
    Li X; Gao L; Wang Z; Guan B; Guan X; Wang B; Han X; Xiao X; Waleed KB; Chandran C; Wu S; Xia Y
    Clin Cardiol; 2018 Mar; 41(3):314-320. PubMed ID: 29575115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.